JP2024167419A5 - - Google Patents

Download PDF

Info

Publication number
JP2024167419A5
JP2024167419A5 JP2024156801A JP2024156801A JP2024167419A5 JP 2024167419 A5 JP2024167419 A5 JP 2024167419A5 JP 2024156801 A JP2024156801 A JP 2024156801A JP 2024156801 A JP2024156801 A JP 2024156801A JP 2024167419 A5 JP2024167419 A5 JP 2024167419A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024156801A
Other languages
Japanese (ja)
Other versions
JP2024167419A (ja
Filing date
Publication date
Priority claimed from JP2018534551A external-priority patent/JP7159048B2/ja
Application filed filed Critical
Publication of JP2024167419A publication Critical patent/JP2024167419A/ja
Publication of JP2024167419A5 publication Critical patent/JP2024167419A5/ja
Pending legal-status Critical Current

Links

JP2024156801A 2016-01-04 2024-09-10 遺伝子修正自己ケラチノサイトを使用する劣性栄養障害型表皮水疱症のための遺伝子療法 Pending JP2024167419A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201662274700P 2016-01-04 2016-01-04
US62/274,700 2016-01-04
US201662414533P 2016-10-28 2016-10-28
US62/414,533 2016-10-28
JP2018534551A JP7159048B2 (ja) 2016-01-04 2017-01-03 遺伝子修正自己ケラチノサイトを使用する劣性栄養障害型表皮水疱症のための遺伝子療法
PCT/US2017/012061 WO2017120147A1 (en) 2016-01-04 2017-01-03 Gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes
JP2022164008A JP7555380B2 (ja) 2016-01-04 2022-10-12 遺伝子修正自己ケラチノサイトを使用する劣性栄養障害型表皮水疱症のための遺伝子療法

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022164008A Division JP7555380B2 (ja) 2016-01-04 2022-10-12 遺伝子修正自己ケラチノサイトを使用する劣性栄養障害型表皮水疱症のための遺伝子療法

Publications (2)

Publication Number Publication Date
JP2024167419A JP2024167419A (ja) 2024-12-03
JP2024167419A5 true JP2024167419A5 (enExample) 2025-04-02

Family

ID=58010360

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018534551A Active JP7159048B2 (ja) 2016-01-04 2017-01-03 遺伝子修正自己ケラチノサイトを使用する劣性栄養障害型表皮水疱症のための遺伝子療法
JP2022164008A Active JP7555380B2 (ja) 2016-01-04 2022-10-12 遺伝子修正自己ケラチノサイトを使用する劣性栄養障害型表皮水疱症のための遺伝子療法
JP2024156801A Pending JP2024167419A (ja) 2016-01-04 2024-09-10 遺伝子修正自己ケラチノサイトを使用する劣性栄養障害型表皮水疱症のための遺伝子療法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2018534551A Active JP7159048B2 (ja) 2016-01-04 2017-01-03 遺伝子修正自己ケラチノサイトを使用する劣性栄養障害型表皮水疱症のための遺伝子療法
JP2022164008A Active JP7555380B2 (ja) 2016-01-04 2022-10-12 遺伝子修正自己ケラチノサイトを使用する劣性栄養障害型表皮水疱症のための遺伝子療法

Country Status (17)

Country Link
US (4) US12173314B2 (enExample)
EP (2) EP3842520A1 (enExample)
JP (3) JP7159048B2 (enExample)
KR (1) KR20180093967A (enExample)
CN (2) CN108473952B (enExample)
AU (2) AU2017205925B2 (enExample)
BR (1) BR112018013576A2 (enExample)
CA (1) CA3008676A1 (enExample)
DK (1) DK3400287T3 (enExample)
ES (1) ES2861453T3 (enExample)
IL (2) IL260038B (enExample)
MX (1) MX2018007986A (enExample)
NZ (1) NZ743682A (enExample)
PT (1) PT3400287T (enExample)
RU (2) RU2753248C2 (enExample)
WO (1) WO2017120147A1 (enExample)
ZA (1) ZA201803962B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108473952B (zh) * 2016-01-04 2022-04-08 小利兰·斯坦福大学托管委员会 使用经遗传矫正的自体角质形成细胞进行的隐性营养不良型大疱性表皮松解症的基因疗法
IT201700094210A1 (it) * 2017-08-17 2019-02-17 Holostem Terapie Avanzate S R L Metodo per produrre lembi cellulari
IT201700104587A1 (it) * 2017-09-19 2019-03-19 Holostem Terapie Avanzate S R L Usi terapeutici di lembi di cellule geneticamente modificate
KR102227434B1 (ko) * 2017-12-29 2021-03-16 진메디신 주식회사 유전자 전달용 세포 시트
RU2730661C2 (ru) * 2018-12-27 2020-08-24 Селл энд Джин Терапи Лтд Генотерапевтический ДНК-вектор на основе генотерапевтического ДНК-вектора VTvaf17, несущий целевой ген, выбранный из группы генов COL1A1, COL1A2, P4HA1, P4HA2, COL7A1, CLCA2, ELN, PLOD1 для повышения уровня экспрессии этих целевых генов, способ его получения и применения, штамм Escherichia coli SCS110-AF/VTvaf17-COL1A1, или Escherichia coli SCS110-AF/VTvaf17-COL1A2, или Escherichia coli SCS110-AF/VTvaf17-P4HA1, или Escherichia coli SCS110-AF/VTvaf17-P4HA2, или Escherichia coli SCS110-AF/VTvaf17-COL7A1, или Escherichia coli SCS110-AF/VTvaf17-CLCA2, или Escherichia coli SCS110-AF/VTvaf17-ELN, или Escherichia coli SCS110-AF/VTvaf17- PLOD1, несущий генотерапевтический ДНК-вектор, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора
AU2020209687A1 (en) 2019-01-18 2021-07-29 Osaka University Composition for use in treating dystrophic epidermolysis bullosa
CN116529361B (zh) * 2019-10-18 2024-01-26 北赛泓升(北京)生物科技有限公司 使用多顺反子sox2、klf4和任选的c-myc产生诱导多能干细胞
AU2020459825A1 (en) * 2020-07-22 2023-03-16 Osaka University Therapeutic agent for dystrophic epidermolysis bullosa
WO2023064806A1 (en) 2021-10-12 2023-04-20 Phoenix Tissue Repair, Inc. Collagen 7 protein replacement therapy
JP2025094280A (ja) * 2022-01-21 2025-06-25 国立大学法人大阪大学 細胞シート

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830725A (en) * 1995-04-28 1998-11-03 The Board Of Trustees For The Leland Stanford Junior University Rapid, stable high-titre production of recombing retrovirus
US20020090725A1 (en) 2000-11-17 2002-07-11 Simpson David G. Electroprocessed collagen
WO2001002433A1 (en) * 1999-07-02 2001-01-11 Human Genome Sciences, Inc. Keratinocyte growth factor-2
FR2857671B1 (fr) * 2003-07-18 2007-10-05 Centre Nat Rech Scient Nouveau procede de culture de keratinocytes et ses applications
CN1916166B (zh) * 2006-09-08 2010-08-11 北京赛尔泰和生物医药科技有限公司 自体角膜上皮的制备方法
US8865199B2 (en) * 2008-11-17 2014-10-21 Ingeneron, Inc. Biomatrix composition and methods of biomatrix seeding
GB201202561D0 (en) * 2012-02-15 2012-03-28 Univ Dundee Treatment of skin disorders
WO2014074503A1 (en) * 2012-11-06 2014-05-15 Imbed Biosciences, Inc. Methods and compositions for wound healing
US8697359B1 (en) 2012-12-12 2014-04-15 The Broad Institute, Inc. CRISPR-Cas systems and methods for altering expression of gene products
CN105087565A (zh) * 2015-08-21 2015-11-25 内蒙古自治区人民医院 一种营养不良型大疱性表皮松解症核苷酸及其应用
CN108473952B (zh) * 2016-01-04 2022-04-08 小利兰·斯坦福大学托管委员会 使用经遗传矫正的自体角质形成细胞进行的隐性营养不良型大疱性表皮松解症的基因疗法
CN109257926A (zh) * 2016-03-18 2019-01-22 英特拉克森公司 用于治疗vii型胶原缺乏的组合物和方法

Similar Documents

Publication Publication Date Title
JP2024167419A5 (enExample)
RU2022120186A3 (enExample)
CN308408861S (enExample)
CN309466832S (enExample)
CN308408044S (enExample)
CN309698583S (enExample)
CN309586230S (enExample)
CN309526363S (enExample)
CN308408077S (enExample)
CN308427861S (enExample)
CN308408909S (enExample)
CN309412369S (enExample)
CN308982082S (enExample)
CN308814445S (enExample)
CN308408093S (enExample)
CN308408218S (enExample)
CN308408253S (enExample)
CN308443405S (enExample)
CN308443376S (enExample)
CN308443309S (enExample)
CN308408275S (enExample)
CN308427856S (enExample)
CN308408321S (enExample)
CN308441810S (enExample)
CN308440173S (enExample)